Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/19/2007EP1866324A1 Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer
12/19/2007EP1866323A2 Glucuronidated nebivolol
12/19/2007EP1866318A2 Thienopyridine compounds, and methods of use thereof
12/19/2007EP1866317A1 4-piperazinothieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
12/19/2007EP1866315A1 1,2,4-triazole derivatives and their use as oxytocin antagonists
12/19/2007EP1866314A1 Novel diazabicyclic aryl derivatives and their medical use
12/19/2007EP1866312A1 Cyclic iminopeptide derivatives
12/19/2007EP1866311A2 Novel compounds
12/19/2007EP1866310A1 2,3-substituted fused pyrimidin-4(3h)-ones as vr1 antagonists
12/19/2007EP1866309A1 A method of preparing a porphyrin derivative, a porphyrin derivative, use of said porphyrin
12/19/2007EP1866306A1 Imidazopyridine derivatives useful as inos inhibitors
12/19/2007EP1866305A1 1,7-naphthyridines as pde4 inhibitors
12/19/2007EP1866304A2 Substituted oxindole derivatives, medicaments containing the latter and use thereof
12/19/2007EP1866302A1 Pyrazole derivatives
12/19/2007EP1866300A1 Arylsulfonyl benzofused heterocycles as 5-ht2a antagonists
12/19/2007EP1866297A1 Process for producing an aminomethyl thiazole compound
12/19/2007EP1866296A1 Desferrithiocin polyether analogues
12/19/2007EP1866292A1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments
12/19/2007EP1866290A1 Prokineticin 1 receptor antagonists
12/19/2007EP1866289A1 Pyrimidine carboxylic acid derivatives and use thereof
12/19/2007EP1866288A1 Indazole squaric acid derivatives as chk1-, chk2- and sgk- inhibitors
12/19/2007EP1866286A1 Pyridine derivatives useful as inhibitors of pkc-theta
12/19/2007EP1866284A1 Biphenyl compounds useful as muscarinic receptor antagonists
12/19/2007EP1866283A2 4-fluorophenyl-derivatives of 1-{[1,5 -bis (4-chlorophenyl) -2-methyl-1h-pyrrol-3-yl]methyl} -4- methylpiperazine, synthesis process and uses thereof
12/19/2007EP1866280A1 Acyl hydrazides as kinase inhibitors, in particular for sgk
12/19/2007EP1866278A1 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists
12/19/2007EP1866277A2 Sulfonyl containing compounds as cysteine protease inhibitors
12/19/2007EP1866275A1 Crystalline forms of pregabalin
12/19/2007EP1866004A2 Intravascular, interstitial or intraorgan medical access device, and manufacturing method thereof, involving nitric oxide
12/19/2007EP1865990A1 Method of treating or preventing type-2 diabetes
12/19/2007EP1865982A1 Hydrogel composition for modulation of topical inflammatory response
12/19/2007EP1865972A2 Treatment or prevention of cancer and precancerous disorders
12/19/2007EP1865971A1 Lubricating composition
12/19/2007EP1865970A2 Minimally invasive clinical treatment method for closure of umbilical hernias
12/19/2007EP1865969A2 Ultra low strength electric field network-mediated ex vivo gene, protein and drug delivery in cells
12/19/2007EP1865968A2 Topical formulations of borinic acid antibodies and their methods of use
12/19/2007EP1865967A2 Compounds, compositions and methods for the treatment of viral infections and other medical disorders
12/19/2007EP1865966A1 The use of non-steroidal anti-inflammatory drugs by inhalation in the treatment of acute and chronic bronchitis
12/19/2007EP1865965A1 2-methylene-19-nor-(23s)-25-dehydro-1 -hydroxyvitamin d3-26,23-lactone and 2-methylene-19-nor-(23r)-25-dehydro-1 -hydroxyvitamin d3-26,23-lactone
12/19/2007EP1865964A1 Topical formulations for use in the treatment or prevention of dermatological conditions
12/19/2007EP1865963A2 Triazadibenzoazulene compounds useful for the treatment and prevention of pain and screening methods therefor
12/19/2007EP1865962A2 Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents
12/19/2007EP1865961A1 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
12/19/2007EP1865960A2 Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
12/19/2007EP1865959A2 Process for preparing pyridoý2,3-d¨pyrimidin-7-one and 3,4-dihydropyrimidoý4,5-d¨pyrimidin-2(1h)-one derivatives
12/19/2007EP1865958A2 Pharmacokinetically improved compounds
12/19/2007EP1865957A2 Method of treating actinic keratosis
12/19/2007EP1865956A2 Piperidinyl substituted cyclohexane-1,4-diamines
12/19/2007EP1865955A2 Method of treating men with testosterone supplement and 5alpha-reductase inhibitor
12/19/2007EP1865954A2 Methods for avoiding edema in the treatment or prevention of ppar gamma-responsive diseases, including cancer
12/19/2007EP1865953A2 Composition comprising n-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof
12/19/2007EP1865952A1 Histamine-containing composition for the treatment of allergic diseases
12/19/2007EP1865951A1 Method for preventing cardiovascular diseases
12/19/2007EP1865950A1 Compounds useful as modulators of the proteasome activity
12/19/2007EP1865948A1 Vitamin mixtures
12/19/2007EP1865947A1 The use of ezetimibe in the prevention and treatment of cholesterol gallstones
12/19/2007EP1865946A2 Method of modulating drug release from a coated substrate
12/19/2007EP1865945A1 Combination therapy for endothelial dysfunction, angina and diabetes
12/19/2007EP1865944A2 Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people
12/19/2007EP1865943A1 Use of acetyl-leucine for preparing a drug for treating balance disorders
12/19/2007EP1865942A2 Novel inhibitors of glutathione-s-transferase
12/19/2007EP1865941A1 Oils of capsaicinoids and methods of making and using the same
12/19/2007EP1865939A2 Metformin methods and formulations for treating chronic constipation
12/19/2007EP1865938A2 Dosing regimes for trans-clomiphene
12/19/2007EP1865937A1 Antibacterial 5',5-disubstituted 3,3'-dialkoxy-2,2'-dihydroxy- 1,1'-biphenyl compounds and related methods
12/19/2007EP1865936A2 Method of regulating mammalian keratinous tissue
12/19/2007EP1865935A1 Bisphosphonates for treating endometriosis
12/19/2007EP1865933A1 Low-concentration capsaicin patch and methods for treating neuropathic pain
12/19/2007EP1865931A1 Transdermal patch
12/19/2007EP1865929A2 Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health
12/19/2007EP1865928A1 Nanoparticulate biphosphonate compositions
12/19/2007EP1865927A1 Topiramate tablet formulation
12/19/2007EP1865923A2 Retinoid immunomodulating kit and composition and uses thereof
12/19/2007EP1865921A1 Pharmaceutical preparation of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide
12/19/2007EP1865917A2 Methods of treating skin and mucosal tissue atrophy using compositions including tensioning polymers
12/19/2007EP1865779A2 Compositions and methods for ameliorating cachexia
12/19/2007EP1865778A2 Methods for avoiding edema in the treatment of metabolic, inflammatory, and cardiovascular disorders
12/19/2007EP1865777A2 Stannsoporfin compositions and administration
12/19/2007EP1865775A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors
12/19/2007EP1865774A1 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/19/2007EP1865773A2 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
12/19/2007EP1865770A2 The genetic risk assessment in heart failure: impact of the genetic variation of nos3
12/19/2007EP1784172A4 Cancer chemotherapy
12/19/2007EP1781656B1 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
12/19/2007EP1771450B1 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
12/19/2007EP1771426B1 Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1b (ptp1b) inhibitors for using as blood-sugar decreasing active ingredients for treating diabetes
12/19/2007EP1756132B1 Process for preparing an iron saccharose complex
12/19/2007EP1740538A4 Bicyclic heterocycles useful as serine protease inhibitors
12/19/2007EP1732562B1 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
12/19/2007EP1711480B1 Novel long-working beta-2-agonists and use thereof as medicaments
12/19/2007EP1701946B1 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
12/19/2007EP1697336B1 Aroylfuranes and aroylthiophenes suitable for the treatment of cancer
12/19/2007EP1682124B1 Pharmaceutical compositions based on idazoxan salt or one of its polymorphs
12/19/2007EP1656351B1 Process for preparation of 4-aryl-nicotinamide derivatives
12/19/2007EP1653930B1 Methods for the stabilization of atorvastatin
12/19/2007EP1628648B1 Deramciclane-fumarate tablets
12/19/2007EP1601358B1 2,5-substituted tetrahydroisoquinolines for use as 5-ht6 modulators
12/19/2007EP1592426B1 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
12/19/2007EP1558262B1 Water-soluble meloxicam granulates
12/19/2007EP1556021B1 Pharmaceutical compositions comprising flavonoids and menthol
1 ... 3455 3456 3457 3458 3459 3460 3461 3462 3463 3464 3465 3466 3467 3468 3469 3470 3471 3472 3473 3474 3475 ... 7860